Clincosm LogoSign in Get a demo

oral squamous cell carcinoma

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
  • (no location specified)
Nov 11, 2023

People Living With HIV, Oral and Oropharyngeal Cancer, and

Not yet recruiting
  • HIV Infections
  • +2 more
  • Group Meeting (Focus Group)
  • Questionnaires
  • San Francisco, California
    University of California, San Francisco
Sep 20, 2023

Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

Recruiting
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • ELISA
  • Fayoum, Egypt
    Fayoum University
Sep 8, 2023

Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oral Mucositis
  • Alfacalcidol Oral Solution
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in China (Tislelizumab, Albumin-Bound Paclitaxel,

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma
  • Beijing, Beijing, China
  • +13 more
Aug 22, 2023

WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

Recruiting
  • Oral Cancer
  • +2 more
  • Biopsy Specimens Histopathology
  • Rawalpindi, Punjab, Pakistan
    Armed Forces Institute of Pathology
Jun 22, 2023

Oral Squamous Cell Carcinoma Trial in Tampere (Punch biopsy)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Punch biopsy
  • Tampere, Pirkanmaa, Finland
    Tampere University Hospital
Jun 5, 2023

Oral Squamous Cell Carcinoma Trial (PRV211 (Intraoperative Cisplatin System))

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • PRV211 (Intraoperative Cisplatin System)
  • (no location specified)
May 30, 2023

TPExtreme Induced Chemotherapy Followed by Surgery and

Recruiting
  • Oral Squamous Cell Carcinoma
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Modified radical surgery
  • Radical surgery
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
May 14, 2023

Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • (no location specified)
May 7, 2023

Salivary LINC00657 asDiagnostic Biomarker for Oral Squamous Cell

Completed
  • Oral Squamous Cell Carcinoma
    • Fayoum, Egypt
      faculty of dentistry, Fayoum university
    Apr 19, 2023

    Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Neck Dissection
    • Elective neck dissection
    • Therapeutic neck dissection
    • (no location specified)
    Apr 10, 2023

    Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Apr 5, 2023

    Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab plus TP, TP)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Camrelizumab plus TP
    • TP
    • Wuhan, Hubei, China
      Hospital of Stomatology, Wuhan University
    Mar 22, 2023

    Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)

    Recruiting
    • Oral Squamous Cell Carcinoma
    • +5 more
    • saliva tube
    • Amiens, Picardie, France
      Amiens University Hospital
    Mar 17, 2023

    Oral Microbioma and Oral Malignant Disease

    Recruiting
    • Oral Cancer
    • +2 more
      • Maastricht, Netherlands
      • +1 more
      Mar 10, 2023

      Oral Cancer, Pharynx Cancer, Sleep Apnea Trial (Ronco-Onco and MAD)

      Not yet recruiting
      • Oral Cancer
      • +4 more
      • Ronco-Onco and MAD
      • (no location specified)
      Jan 30, 2023

      Oral Squamous Cell Carcinoma Trial in Shanghai (Camrelizumab Plus Docetaxel and Cisplatin)

      Recruiting
      • Oral Squamous Cell Carcinoma
      • Camrelizumab Plus Docetaxel and Cisplatin
      • Shanghai, Shanghai, China
        Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Ton
      Nov 9, 2022

      Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Camrelizumab (anti-PD-1 inhibitor), Apatinib

      Recruiting
      • Oral Squamous Cell Carcinoma
      • +3 more
      • Camrelizumab (anti-PD-1 inhibitor)
      • Apatinib (anti-VEGFR inhibitor)
      • Shanghai, Shanghai, China
        Ninth People's Hospital, Shanghai Jiao Tong University School of
      Oct 8, 2022

      Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

      Recruiting
      • Oral Squamous Cell Carcinoma
      • +3 more
      • Toripalimab (anti-programmed death-1 inhibitor)
      • +4 more
      • Shanghai, Shanghai, China
        Ninth People's Hospital, Shanghai Jiao Tong University School of
      Oct 8, 2022

      Oral Squamous Cell Carcinoma Trial in New York (Chemical sensitivity, Mechanical sensitivity)

      Recruiting
      • Oral Squamous Cell Carcinoma
      • Chemical sensitivity
      • Mechanical sensitivity
      • New York, New York
        New York University College of Dentistry
      Sep 26, 2022

      Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab, Camrelizumanb plus TPF)

      Active, not recruiting
      • Oral Squamous Cell Carcinoma
      • Wuhan, Hubei, China
        Hospital of Stomatology, Wuhan University
      Aug 17, 2022

      Oral and Throat Cancers Using OralViome Cancer Testing System

      Recruiting
      • Oral Squamous Cell Carcinoma
      • +2 more
      • OralViome Cancer Testing System
      • New York, New York
        NYMC
      Aug 5, 2022

      Postoperative Radiotherapy for Oral Squamous Cell Carcinoma

      Recruiting
      • Radiotherapy
      • +3 more
        • Shanghai, Shanghai, China
          Ninth People's Hospital, Shanghai Jiao Tong University School of
        Jul 12, 2022

        Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in Guangzhou, Guanzhou (sintilimab, paclitaxel,

        Recruiting
        • Oral Squamous Cell Carcinoma
        • Oropharyngeal Squamous Cell Carcinoma
        • sintilimab, paclitaxel, carboplatin
        • Surgical resection
        • Guangzhou, Guangdong, China
        • +1 more
        Feb 23, 2022